Natriuretic Peptides

Peptides that regulate the WATER-ELECTROLYTE BALANCE in the body, also known as natriuretic peptide hormones. Several have been sequenced (ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; C-TYPE NATRIURETIC PEPTIDE).

Also Known As:

Networked: 1354 relevant articles (38 outcomes, 158 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Januzzi, James L: 33 articles (08/2015 - 09/2006)
2.	Burnett, John C: 26 articles (12/2015 - 02/2002)
3.	Richards, A Mark: 22 articles (08/2015 - 01/2002)
4.	Mueller, Christian: 17 articles (04/2015 - 07/2007)
5.	Maisel, Alan: 15 articles (08/2014 - 09/2004)
6.	de Lemos, James A: 15 articles (12/2013 - 01/2003)
7.	Maisel, Alan S: 14 articles (06/2015 - 09/2005)
8.	Emdin, Michele: 12 articles (04/2015 - 09/2003)
9.	Vuolteenaho, Olli: 11 articles (09/2013 - 03/2004)
10.	Nicholls, M Gary: 11 articles (11/2008 - 01/2002)

Related Diseases

1.	Heart Failure 01/01/1996 - "Providing open access echocardiography, and/or targeting this resource to the most deserving cases by measuring plasma natriuretic peptides may help to optimize the use of this technique while improving the diagnosis of heart failure patients. " 01/01/2009 - "Over the past decade natriuretic peptides (NPs) became a very useful tool in the management of heart failure patients. " 03/01/2013 - "Improvement in structural and functional echocardiographic parameters during chronic heart failure therapy guided by natriuretic peptides: mechanistic insights from the ProBNP Outpatient Tailored Chronic Heart Failure (PROTECT) study." 10/01/2015 - "While the natriuretic peptides remain the gold standard heart failure biomarker, they are plagued by their non-specific nature; furthermore, the strategy of natriuretic peptide-guided care remains elusive. " 01/01/2011 - "Monitoring treatment efficacy and assessing outcome by serial measurements of natriuretic peptides in acute decompensated heart failure (ADHF) patients may help to improve outcome. "
2.	Myocardial Infarction 01/01/2014 - "Natriuretic peptides as an adjunctive treatment for acute myocardial infarction: insights from the meta-analysis of 1,389 patients from 20 trials." 09/01/2005 - "Few studies have compared the relative prognostic value of different natriuretic peptides after acute myocardial infarction (AMI). " 02/01/2014 - "Changes of natriuretic peptides concentration in early phase of acute myocardial infarction." 08/01/2013 - "Patients with increased blood concentrations of natriuretic peptides (NPs) have poor cardiovascular outcomes after myocardial infarction (MI). " 08/01/2013 - "Association between natriuretic peptides and mortality among patients admitted with myocardial infarction: a report from the ACTION Registry(R)-GWTG™."
3.	Heart Diseases (Heart Disease) 03/14/2008 - "Natriuretic peptides (NPs) show promise in screening asymptomatic populations for structural heart disease, but little is known about their use in student athletes. " 01/01/2010 - "An astonishing amount of clinical studies have established cardiac natriuretic peptides and their molecular precursors as useful markers of heart disease. " 01/01/2008 - "Several studies have demonstrated that higher circulating levels of natriuretic peptides represent a strong independent risk factor for major cardiovascular complications and/or death, even in extra-cardiac diseases. " 11/01/2004 - "2. Recent studies have identified additional modes of action of the natriuretic peptides that may also confer cardioprotective benefits, especially in heart disease. " 12/19/2015 - "Using natriuretic peptides to detect cardiac diseases in horses."
4.	Acute Coronary Syndrome 01/01/2004 - "Taken together, the acute actions of natriuretic peptides on the coronary vasculature and in myocardial ischaemia suggest a profile of activity that may be therapeutically beneficial in the management of patients with acute coronary syndromes." 08/01/2010 - "Patients with acute coronary syndromes and elevated levels of natriuretic peptides: the results of the AVANT GARDE-TIMI 43 Trial." 05/01/2013 - "The potential role of natriuretic peptides in acute coronary syndrome stratification." 11/01/2012 - "B-type natriuretic peptides in acute coronary syndromes: implications in an aging population." 08/01/2010 - "Elevated natriuretic peptides (NPs) are associated with an increased cardiovascular risk following acute coronary syndromes (ACSs). "
5.	Atherosclerosis 01/01/2010 - "Natriuretic peptides (NPs) have potent antiproliferative and antimigratory effects on vascular smooth-muscle cells (VSMCs) and, in atherosclerosis, participate in vascular remodeling, in which the expression of NP clearance receptors (NPR-Cs) is upregulated both in endothelium and in VSMCs. " 09/01/2004 - "[Natriuretic peptides and atherosclerosis]." 01/01/2004 - "In recent years however a new pharmacological approach has evolved as a result of (i) the dissociation of endothelial dysfunction and vascular pathology from increased blood pressure; (ii) the recognition that endothelial dysfunction regards not only the vascular reactivity, but also promotes atherosclerosis and thrombosis; and (iii) an improved understanding of the complexity of local-tissue renin angiotensin system and of the vasodilatory and cytoprotective role of natriuretic peptides. " 07/01/2014 - "Moreover, the natriuretic peptides have been implicated in the protection against atherosclerosis, thrombosis, and myocardial ischaemia. " 01/01/2008 - "Brain natriuretic peptides as biomarkers for atherosclerosis."

Related Drugs and Biologics

1.	Biological Markers (Surrogate Marker)
2.	pro-brain natriuretic peptide (1-76)
3.	Brain Natriuretic Peptide (Natrecor)
4.	Hormones
5.	Atrial Natriuretic Factor (ANF)
6.	Neprilysin (Neutral Endopeptidase)
7.	atrial natriuretic factor receptor A
8.	Insulin (Novolin)
9.	Captopril (Capoten)
10.	Perindopril

Related Therapies and Procedures

1.	Renal Dialysis (Hemodialysis)
2.	Cardiac Resynchronization Therapy
3.	Ligation
4.	Organ Transplantation
5.	Surgical Instruments (Clip)